CLOV vs VTAK · rev $1.37B vs rev $420.0K
Clover Health Investments Corp (CLOV) versus Catheter Precision Inc. (VTAK) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Catheter Precision Inc. (VTAK) is a medical devices company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VTAK revenue for 2024-12-31 was $420.0K. Net income was -$16.6M. Revenue was down 5.0% from 2023-12-31 to 2024-12-31. VTAK currently screens at market cap $3.0M.
CLOV currently screens at market cap $1.55B. VTAK currently screens at market cap $3.0M.
Not investment advice. Open the CLOV and VTAK stock pages for the full models.
Not investment advice.